CLINICAL MASS SPECTROMETRY MARKET ANALYSIS

Clinical Mass Spectrometry Market, by Product Type (Gas chromatography–mass spectrometry (GC-MS) instrument , Liquid chromatography–mass spectrometry (LC- MS) instrument, MALDI-TOF mass spectrometer, Capillary electrophoresis–mass spectrometry, and Ion mobility spectrometry-mass spectrometry), by Application (Clinical Testing, Proteomics, and Drug discovery), by End User (Research Laboratories, Diagnostic Laboratories, and Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI193
Pages :169
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Clinical Mass Spectrometry Market - Regional Insights

On the basis of region, the global clinical mass spectrometry market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold the largest share in the clinical mass spectrometry market over the forecast period, owing to Research and development activities, coupled with governmental support are factors driving growth of the North America market. For instance, the Federation of analytical Chemistry and Spectrometry Societies, and American Society for Mass Spectrometry, which was formed in 1969, with over 7,500 scientists working together on advancing clinical application of mass spectrometry and allied topics in academic, industrial, and governmental fields. This has created a strong research base in North America which is contributing to the growth of the clinical mass spectrometry market in the region.